Table 1.

Disposition of patients by treatment group (all treated patients)

CharacteristicNonrandomizedOxcarbazepine
2400 mg/d300 mg/dTotal
* Two patients discontinued before receiving a single dose of oxcarbazepine during the double-blind treatment phase.
Enrolled475145143
Randomized0514596
Included in efficacy analyses (intent-to-treat)*0494594
Included in safety analyses (all treated)475145143
Included in pharmacokinetic analysis154643104